Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventions.

× No keyword cloud information.

12 in total

1. Effects of different thrombolytic treatment regimen with abciximab and tirofiban on platelet aggregation and platelet-leukocyte interactions: a subgroup analysis from the GUSTO V and FASTER trials.

Authors: Ulf Bertram; Martin Moser; Karlheinz Peter; Helmut F Kuecherer; Raffi Bekeredjian; Andreas Straub; Thomas K Nordt; Christoph Bode; Johannes Ruef
Journal: J Thromb Thrombolysis Date: 2002-12 Impact factor: 2.300

2. Inhibition of platelet function by abciximab or high-dose tirofiban in patients with STEMI undergoing primary PCI: a randomised trial.

Authors: J W van Werkum; W B M Gerritsen; J C Kelder; C M Hackeng; S M Ernst; V H M Deneer; M J Suttorp; B J W M Rensing; H W M Plokker; J M Ten Berg
Journal: Neth Heart J Date: 2007 Impact factor: 2.380

3. Does glycoprotein IIB/IIIA resistance exist?

Authors: J J J Smit; A W J van 't Hof
Journal: Neth Heart J Date: 2007 Impact factor: 2.380

4. Pharmacodynamic effects of cangrelor and clopidogrel: the platelet function substudy from the cangrelor versus standard therapy to achieve optimal management of platelet inhibition (CHAMPION) trials.

Authors: Dominick J Angiolillo; David J Schneider; Deepak L Bhatt; William J French; Matthew J Price; Jorge F Saucedo; Tamaz Shaburishvili; Kurt Huber; Jayne Prats; Tiepu Liu; Robert A Harrington; Richard C Becker
Journal: J Thromb Thrombolysis Date: 2012-07 Impact factor: 2.300

5. Pharmacokinetic and pharmacodynamic properties of batifiban coadministered with antithrombin agents in Chinese healthy volunteers.

Authors: Xiao-Meng He; Ying Zhou; Jie Li; San-Lan Wu; Meng-Meng Jia; Ming-Zhou Liu; Hui Chen; Ke Chen; Sheng-Feng Li; Yao-Hua Wang; Wei-Yong Li
Journal: J Huazhong Univ Sci Technolog Med Sci Date: 2013-10

6. Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention.

Authors: Monica Verdoia; Lucia Barbieri; Alon Schaffer; Ettore Cassetti; Gabriella Di Giovine; Giorgio Bellomo; Paolo Marino; Fabiola Sinigaglia; Giuseppe De Luca
Journal: J Thromb Thrombolysis Date: 2014-04 Impact factor: 2.300

Review 7. Anti-platelet therapy: glycoprotein IIb-IIIa antagonists.

Authors: David J Schneider
Journal: Br J Clin Pharmacol Date: 2011-10 Impact factor: 4.335

8. Different effects of tirofiban and aspirin plus clopidogrel on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion.

Authors: Y-J Yang; J-L Zhao; S-J You; Y-J Wu; Z-C Jing; W-X Yang; L Meng; Y-W Wang; R-L Gao
Journal: Heart Date: 2005-12-30 Impact factor: 5.994

9. Single high-dose bolus tirofiban with high-loading-dose clopidogrel in primary coronary angioplasty.

Authors: Tuba Bilsel; Tamer Akbulut; Kemal Yesilcimen; Sait Terzi; Nurten Sayar; Sennur Unal Dayi; Haldun Akgoz; Mehmet Ergelen; Figen Ciloglu
Journal: Heart Vessels Date: 2006-03 Impact factor: 2.037

10. Safety and feasibility of a novel dosing regimen of tirofiban administered in patients with acute myocardial infarction with ST elevation before primary coronary angioplasty: a pilot study.

Authors: Waclaw Kochman; Slawomir Dobrzycki; Konrad S Nowak; Stefan Chlopicki; Pawel Kralisz; Przemyslaw Prokopczuk; Hanna Bachorzewska-Gajewska; Kamil Gugala; Maciej Niewada; Grzegorz Mezynski; Bogdan Poniatowski; Janusz Korecki; Wlodzimierz J Musial
Journal: J Thromb Thrombolysis Date: 2004-04 Impact factor: 2.300